Patents by Inventor Frank Biedermann

Frank Biedermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230258556
    Abstract: The present invention relates to the use of monodisperse nanozeolites with a specific particle size distribution in analytical determination methods, methods for the qualitative and quantitative determination of one or more neutral, zwitterionic or positively charged bioanalytes in a sample, in particular in saline media, using such nanozeolites, and new chemosensors based on such nanozeolites with doping with functionalised dyes or indicators.
    Type: Application
    Filed: July 2, 2021
    Publication date: August 17, 2023
    Inventors: Frank Biedermann, Laura Grimm, Stephan Sinn
  • Patent number: 11491227
    Abstract: The invention provides hydrogel, wherein the hydrogel has a supramolecular cross-linked network obtainable or obtained from the complexation of an aqueous composition including a host, such as cucurbituril, and one or more polymers having suitable guest functionality. One or more polymers in the aqueous composition may have a molecular weight of 50 kDa or more, such as 200 kDa or more. The hydrogel may hold a component, such as a therapeutic compound or a biological molecule. The hydrogels are suitable for use in medicine.
    Type: Grant
    Filed: February 20, 2013
    Date of Patent: November 8, 2022
    Assignee: CAMBRIDGE ENTERPRISE LIMITED
    Inventors: Oren Scherman, Eric Appel, Xian Jun Loh, Frank Biedermann, Matthew Rowland
  • Publication number: 20150110772
    Abstract: The invention provides hydrogel, wherein the hydrogel has a supramolecular cross-linked network obtainable or obtained from the complexation of an aqueous composition including a host, such as cucurbituril, and one or more polymers having suitable guest functionality. One or more polymers in the aqueous composition may have a molecular weight of 50 kDa or more, such as 200 kDa or more. The hydrogel may hold a component, such as a therapeutic compound or a biological molecule. The hydrogels are suitable for use in medicine.
    Type: Application
    Filed: February 20, 2013
    Publication date: April 23, 2015
    Inventors: Oren Scherman, Eric Appel, Xian Jun Loh, Frank Biedermann, Matthew Rowland